Saying 1,000 words: 'Selfies' could to improve medication adherence

Cara Livernois | | Health Exec | Precision Medicine

Monitoring medication adherence may take a step forward with smartphone apps that require patients to snap 'selfies' before and after they take medication.

Appropriately titled “selfie medicine,” the app requires patients to take medications and then upload video proof to their clinic. This new avenue of remote patient monitoring aims to increase medication adherence.

Additionally, these types of monitoring apps are being researched with funding provided by the National Institute on Drug Abuse to see if patients with opioid addictions could use the app to avoid a relapse.

"If we can keep patients engaged, we can keep them in treatment longer," lead researcher Judith Tsui, of the University of Washington School of Medicine in Seattle, told the New York Times.

Read the full story below:

Selfie Medicine: Phone Apps Push People to Take Their Pills

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

AI in Healthcare
Nat’l Academy of Medicine sets ‘priorities for action’ as healthcare mulls next moves with AI

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it. 

Cardiovascular Business
Biden chooses semaglutide for next round of Medicare price negotiations—Trump gets final say

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

AI in Healthcare
4 ways HHS plans to help shape a national strategy for healthcare AI

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.